kwd 2131 has been researched along with Allergic Reaction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pegelow, KO; Strandberg, K | 1 |
| Arner, B; Hegardt, B | 1 |
2 trial(s) available for kwd 2131 and Allergic Reaction
| Article | Year |
|---|---|
Evaluation of the bronchodilating and antiallergic properties of a beta-adrenoceptor stimulant, KWD 2131, in asthmatic patients.
Topics: Adrenergic beta-Antagonists; Adult; Allergens; Asthma; Bronchodilator Agents; Chronic Disease; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Heart Rate; Histamine; Humans; Hypersensitivity; Male; Peak Expiratory Flow Rate; Random Allocation; Terbutaline; Tremor | 1980 |
Evaluation of the inhibition of allergen-induced intracutaneous reactions by a new beta-agonist, KWD 2131, and by terbutaline.
Topics: Adrenergic beta-Agonists; Adult; Allergens; Clinical Trials as Topic; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypersensitivity; Male; Terbutaline | 1981 |